Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics

BACKGROUND: The development of plasma biomarkers could facilitate early detection, risk assessment and therapeutic monitoring in Alzheimer's disease (AD). Alterations in ceramides and sphingomyelins have been postulated to play a role in amyloidogensis and inflammatory stress related neuronal a...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xianlin, Rozen, Steve, Boyle, Stephen H., Hellegers, Caroline, Cheng, Hua, Burke, James R., Welsh-Bohmer, Kathleen A., Doraiswamy, P. Murali, Kaddurah-Daouk, Rima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136924/
https://www.ncbi.nlm.nih.gov/pubmed/21779331
http://dx.doi.org/10.1371/journal.pone.0021643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136924/
https://www.ncbi.nlm.nih.gov/pubmed/21779331
http://dx.doi.org/10.1371/journal.pone.0021643

Ejemplares similares